Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers.
Moderna rose by more than 12%, while Novavax and CureVac also rallied after U.S. health officials confirmed the first American death caused by the H5N1 bird flu in Louisiana. The latest weekly tally of Covid-19 cases also rose sharply.
Novo Nordisk shares fell after President-elect Donald Trump vowed to "tariff Denmark at a very high level" if the nation refused to hand sovereignty over Greenland to the U.S.
WuXi Biologics agreed to sell an overseas vaccine facility to Merck for $500 million, a move that could strengthen the Chinese drugmaker's cash flow and margins as it navigates global uncertainties.
MAIA Biotechnology's shares rallied after the biotech firm struck a deal with BeiGene to explore development of a telomere-targeting anticancer agent. A telomere is a chromosome feature thought to play a role in cancer and aging, among other things.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
January 07, 2025 17:59 ET (22:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.